Efficacy of Vitamin D Supplementation in relapsing-remitting Multiple
Efficacy of Vitamin D Supplementation in relapsing-remitting Multiple Sclerosis
What it found
The trial ended early for another reason (see below).
18 months
Read by software from the paper's abstract
What was tested
Treatment tested
- Cholecalciferol
Vitamin D receptor agonist
What it measured
Main measures
Cumulative number of new hyperintense lesions in T2-weighted cranial MR imaging
MRI lesions
Other measures (1)
Annualized relapse rate, proportion of relapse-free patients, disease progression, percentage of patients without disease activity, proportion of patients with a conversion into a definitive MS (only in CIS patients), other MRI parameters (number / volume of new hypointense T1 lesions, brain atrophy, number of lesions absorbing contrast agent, spectroscopy) cognition, fatigue, depression, Retinal
RelapsesMRI lesionsBrain volume lossRetina scans (OCT)Thinking and memoryFatigueMood and sleepQuality of life (reported by participants)
Who could take part
Relapsing MS
Show the full criteria
Inclusion criteria
Inclusion: Informed consent Exclusion: Any other MS-course than RRMS
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
To assess efficacy of Vitamin D supplementation in relapsing-remitting Multiple Sclerosis
Papers
Loading reviews and guidelines…
Related trials
- Effect of Probiotics on Relapsing-Remitting Multiple Sclerosis
Not a drug-phase study · Completed
No results found
- Targeting the Gut Dysbiosis to Treat Inflammation-driven Synaptopathy
Not a drug-phase study · Status unknown
No results found
- Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis
Phase 4 · Status unknown
No results found
- Efficacy of Diet on Quality of Life in Multiple Sclerosis
Not a drug-phase study · Running, not recruiting
Still running
- Prebiotic vs Probiotic in Multiple Sclerosis
Not a drug-phase study · Completed
Paper found, not read
- Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance
Not a drug-phase study · Status unknown
No results found
History
Started
Aug 2011